KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash from Operations (2018 - 2026)

Castle Biosciences' Cash from Operations history spans 8 years, with the latest figure at 26931000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 10.53% to 26931000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 64347000.0, a 0.8% decrease, with the full-year FY2025 number at 64347000.0, down 0.8% from a year prior.
  • Cash from Operations hit 26931000.0 in Q4 2025 for Castle Biosciences, up from 22631000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for CSTL hit a ceiling of 26931000.0 in Q4 2025 and a floor of 25439000.0 in Q1 2023.
  • Historically, Cash from Operations has averaged 3147450.0 across 5 years, with a median of 3708500.0 in 2021.
  • Biggest five-year swings in Cash from Operations: tumbled 1346.61% in 2021 and later soared 733.86% in 2024.
  • Tracing CSTL's Cash from Operations over 5 years: stood at 2781000.0 in 2021, then tumbled by 115.75% to 6000000.0 in 2022, then skyrocketed by 409.78% to 18587000.0 in 2023, then surged by 31.09% to 24365000.0 in 2024, then increased by 10.53% to 26931000.0 in 2025.
  • Business Quant data shows Cash from Operations for CSTL at 26931000.0 in Q4 2025, 22631000.0 in Q3 2025, and 20821000.0 in Q2 2025.